ISDA

Deposition Date 2012-09-17

Release Date 2012-12-05

Last Version Date 2023-09-20

Entry Detail

PDB ID:

4H4O

Keywords:

Hydrolase/Hydrolase inhibitor

Title:

Crystal Structure of HIV-1 Reverse Transcriptase (RT) in Complex with (E)-3-(3-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)- 4-fluorophenoxy)-5-fluorophenyl)acrylonitrile (JLJ506), A Non-nucleoside inhibitor

Biological Source:

Source Organism:

Human immunodeficiency virus type 1 BH10 (Taxon ID: 11678)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.90 Å

R-Value Free:

0.26

R-Value Work:

0.23

R-Value Observed:

0.23

Space Group:

C 1 2 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Reverse transcriptase/ribonuclease H, Exoribonuclease H, p66 RT
Gene (Uniprot):gag-pol
Mutations:C280S, K172A, K173A
Chain IDs:A
Chain Length:557
Number of Molecules:1
Biological Source:Human immunodeficiency virus type 1 BH10

UniProt ID:P03366 Pfam ID:PF00078, PF06817, PF06815, PF00075 EC:3.1.26.13

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Reverse transcriptase/ribonuclease H, Exoribonuclease H, p51 RT
Gene (Uniprot):gag-pol
Mutations:C280S
Chain IDs:B
Chain Length:428
Number of Molecules:1
Biological Source:Human immunodeficiency virus type 1

UniProt ID:P03366 Pfam ID:PF00078, PF06817, PF06815, PF00075 EC:3.1.26.13

Ligand Molecules

506

Primary Citation

Crystal Structures of HIV-1 Reverse Transcriptase with Picomolar Inhibitors Reveal Key Interactions for Drug Design.

Frey, K.M, Bollini, M, Mislak, A.C, Cisneros, J.A, Gallardo-Macias, R, Jorgensen, W.L, Anderson, K.S.Show

J.Am.Chem.Soc. 134 19501 19503 (2012)

PMID: 23163887 DOI: 10.1021/ja3092642

Abstact

X-ray crystal structures at 2.9 Å resolution are reported for two complexes of catechol diethers with HIV-1 reverse transcriptase. The results help elucidate the structural origins of the extreme antiviral activity of the compounds. The possibility of halogen bonding between the inhibitors and Pro95 is addressed. Structural analysis reveals key interactions with conserved residues P95 and W229 of importance for design of inhibitors with high potency and favorable resistance profiles.

Legend

Protein

Chemical

Disease

Primary Citation of related structures